Sunil Agarwal – Juno Therapeutics

Sunil Agarwal, M.D.

President of Research and Development

Sunil Agarwal, M.D., is our President of Research and Development and joined Juno in April 2017. Previously, Dr. Agarwal was Chief Medical Officer and Executive Vice President at Ultragenyx. Prior to his tenure at Ultragenyx, Dr. Agarwal worked in a number of senior leadership roles at Genentech, Inc., most recently as Senior Vice President, Global Development Head, Ophthalmology, Metabolism, Neuroscience, Immunology and Infectious Diseases. He was responsible for the development of programs in these areas from proof of concept (PoC) through Phase IV. He has led global approvals of multiple therapies and successfully built and led large global development organizations in multiple geographies. Dr. Agarwal received his bachelor of science in Neuro-Biology at Cornell University and earned his medical degree from Tufts University School of Medicine. He completed his residency at Children’s National Medical Center, Washington, D.C., and subsequently joined the faculty at George Washington University School of Medicine.